B Kron

497 total citations
10 papers, 405 citations indexed

About

B Kron is a scholar working on Surgery, Nephrology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, B Kron has authored 10 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 3 papers in Nephrology and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in B Kron's work include Lipoproteins and Cardiovascular Health (5 papers), Electrolyte and hormonal disorders (2 papers) and Neonatal Health and Biochemistry (2 papers). B Kron is often cited by papers focused on Lipoproteins and Cardiovascular Health (5 papers), Electrolyte and hormonal disorders (2 papers) and Neonatal Health and Biochemistry (2 papers). B Kron collaborates with scholars based in Sweden, United States and Finland. B Kron's co-authors include Ola Samuelsson, P.-O. Attman, H. Mulec, Robert Larsson, Carolyn Knight‐Gibson, Petar Alaupovic, Lars Weiss, Hans Wedel, Per Sjöström and T. LINDÉN and has published in prestigious journals such as The American Journal of Medicine, Nephrology Dialysis Transplantation and European Journal of Clinical Pharmacology.

In The Last Decade

B Kron

10 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
B Kron Sweden	7	247	154	146	92	45	10	405
Per-Ola Attman Sweden	10	216 0.9×	206 1.3×	176 1.2×	53 0.6×	24 0.5×	15	395
Won Ki Min South Korea	12	193 0.8×	181 1.2×	75 0.5×	47 0.5×	28 0.6×	37	521
B. O'Connor United Kingdom	10	247 1.0×	43 0.3×	216 1.5×	114 1.2×	51 1.1×	16	481
J Pedro‐Botet Spain	11	241 1.0×	70 0.5×	203 1.4×	62 0.7×	42 0.9×	31	478
C Hottelart France	10	144 0.6×	168 1.1×	126 0.9×	73 0.8×	17 0.4×	15	433
S. Madsen Denmark	11	288 1.2×	159 1.0×	93 0.6×	64 0.7×	17 0.4×	47	648
DN O'Neal Australia	10	160 0.6×	48 0.3×	291 2.0×	151 1.6×	25 0.6×	17	436
John T. Monyak United States	11	449 1.8×	75 0.5×	246 1.7×	75 0.8×	59 1.3×	23	652
Priyanka Kakar United States	9	143 0.6×	37 0.2×	101 0.7×	145 1.6×	24 0.5×	13	328
J.W. Persaud United Kingdom	15	194 0.8×	171 1.1×	189 1.3×	82 0.9×	31 0.7×	20	470

Countries citing papers authored by B Kron

Since Specialization

Citations

This map shows the geographic impact of B Kron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Kron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Kron more than expected).

Fields of papers citing papers by B Kron

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Kron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Kron. The network helps show where B Kron may publish in the future.

Co-authorship network of co-authors of B Kron

This figure shows the co-authorship network connecting the top 25 collaborators of B Kron. A scholar is included among the top collaborators of B Kron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Kron. B Kron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Stockelberg, Dick, et al.. (2003). [CPP (Cost Per Patient) is functioning well in the everyday care. The myeloma care program in Vastra Gotaland--an illustrative example].. PubMed. 100(42). 3316–8. 1 indexed citations

2.

Samuelsson, Ola, H. Mulec, Carolyn Knight‐Gibson, et al.. (1997). Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. Nephrology Dialysis Transplantation. 12(9). 1908–1915. 179 indexed citations

3.

Samuelsson, Ola, P.-O. Attman, Carolyn Knight‐Gibson, et al.. (1997). Effect of Gemfibrozil on Lipoprotein Abnormalities in Chronic Renal Insufficiency: A Controlled Study in Human Chronic Renal Disease. Nephron. 75(3). 286–294. 21 indexed citations

4.

Sjöström, Per, et al.. (1995). Determinants of furosemide delivery to its site of action.. PubMed. 43 Suppl 1. S38–41. 6 indexed citations

5.

Samuelsson, Ola, P.-O. Attman, Carolyn Knight‐Gibson, et al.. (1994). Lipoprotein abnormalities without hyperlipidaemia in moderate renal insufficiency. Nephrology Dialysis Transplantation. 9(11). 1580–1585. 34 indexed citations

6.

Kron, B, et al.. (1994). Acute Tolerance to Furosemide. Pretreatment with Captopril or Prazosin does not Influence Diuresis and Natriuresis. Scandinavian Journal of Urology and Nephrology. 28(4). 337–344. 7 indexed citations

7.

Kron, B, et al.. (1993). Changes in renal clearance of furosemide due to changes in renal blood flow and plasma albumin concentration. European Journal of Clinical Pharmacology. 45(2). 135–139. 8 indexed citations

8.

Wiklund, Olov, B. Angelin, Michael Bergman, et al.. (1993). Pravastatin and gemfibrozil alone and in combination for the treatment of hypercholesterolemia. The American Journal of Medicine. 94(1). 13–20. 143 indexed citations

9.

Wiklund, Olov, B. Angelin, Mathias Bergman, et al.. (1993). Pravastatin and Gemfibrozil Alone and in Combination for the Treatment of Hypercholesterolemia. The Endocrinologist. 3(3). 230–230. 2 indexed citations

10.

Ganrot, P. O., Bengt Curman, & B Kron. (1987). Type 2 diabetes. Primary vascular disorder with metabolic symptoms?. Medical Hypotheses. 24(1). 77–86. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact